Are These 2 Beaten-Down Biotech Stocks Worth the Risk?
Catalyst Pharmaceuticals and Novavax have had tough go of it in May. Could better days be close at hand?
Catalyst Pharmaceuticals
CPRX
CPRX
$3.63
$0.00
0.0%
BATS BZX Real Time Price as of June 26, 2019, 4:00 p.m.
View Interactive CPRX Charts
A development-stage pharmaceutical company focused on the acquisition, development and commercialization of prescription drugs for the treatment of drug addiction.
News & Analysis: Catalyst Pharmaceuticals
Catalyst Pharmaceuticals Posts Strong Q1 Sales for Firdapse
But serious questions remain about potential competition from a newly approved rival drug.
Why Catalyst Pharmaceuticals Briefly Spiked Today
Catalyst posted outstanding first-quarter numbers this morning, but the good times may not last.
Catalyst Pharmaceuticals Inc (CPRX) Q1 2019 Earnings Call Transcript
CPRX earnings call for the period ending March 31, 2019.
Why Catalyst Pharmaceuticals Stock Is Jumping Today
The drugmaker is rebounding after a big plunge earlier this week that might have been a little overdone.
Why Catalyst Pharmaceuticals Is Getting Crushed Today
Catalyst's shares are in free fall today after the FDA's surprise approval of a rival LEMS medication.
Why Catalyst Pharmaceuticals, Inc. Soared in March
Catalyst's new orphan drug is off to a strong start.
3 Top Biotech Stocks to Buy Right Now
These biotech stocks could have a lot of room to run.
Why Catalyst Pharmaceuticals Stock Is Popping Today
The drugmaker's Q4 earnings release was a big hit with investors.
Catalyst Pharmaceuticals Inc (CPRX) Q4 2018 Earnings Conference Call Transcript
CPRX earnings call for the period ending December 31, 2018.
